Literature DB >> 7678160

Antimutagenicity of cell fractions of microorganisms on potent mutagenic pyrolysates.

X B Zhang1, Y Ohta.   

Abstract

The inactivation of 3-amino-1,4-dimethyl-5H-pyrido[4,3-b]indole (Trp-P-1) and 2-amino-6-methyldipyrido[1,2-a: 3',2'-d]imidazole (Glu-P-1) by binding of mutagenic pyrolysate to fractions of microorganisms (their desmutagenic and bio-antimutagenic activity) was investigated. All strains bound Trp-P-1 effectively, but Glu-P-1 to a lesser extent. The Gram-negative bacteria (GNB) could bind about 10-20 micrograms/mg of Trp-P-1 more than the Gram-positive bacteria (GPB), and about 50-60 micrograms/mg more than the yeasts. The cell wall skeletons of all strains tested had great binding ability, but in the cytoplasm of all strains tested it was lower. The peptidoglycan, outer membrane, and glucan isolate from the cell wall skeletons showed the highest binding ability to Trp-P-1. The cell wall skeletons of the tested strains greatly inhibited the mutagenicity induced by Trp-P-1, and to a lower extent that of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx). Although the cultured broth and solution of cells extracted by phosphate buffer (pH 7.0) showed antimutagenicity against Trp-P-1, this activity was lower than the binding of Trp-P-1 to the cells. The cultured broth and freeze-dried cytoplasms of yeast cells showed bio-antimutagenicity towards Trp-P-1, but those of all bacteria tested did not.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7678160     DOI: 10.1016/0165-1218(93)90003-v

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  8 in total

1.  Surface binding of aflatoxin B(1) by lactic acid bacteria.

Authors:  C A Haskard; H S El-Nezami; P E Kankaanpää; S Salminen; J T Ahokas
Journal:  Appl Environ Microbiol       Date:  2001-07       Impact factor: 4.792

2.  Ability of probiotic Lactobacillus casei DN 114001 to bind or/and metabolise heterocyclic aromatic amines in vitro.

Authors:  Adriana Nowak; Zdzislawa Libudzisz
Journal:  Eur J Nutr       Date:  2009-05-16       Impact factor: 5.614

3.  Binding rather than metabolism may explain the interaction of two food-Grade Lactobacillus strains with zearalenone and its derivative (')alpha-earalenol.

Authors:  Hani El-Nezami; Nektaria Polychronaki; Seppo Salminen; Hannu Mykkänen
Journal:  Appl Environ Microbiol       Date:  2002-07       Impact factor: 4.792

Review 4.  Mechanisms and therapeutic effectiveness of lactobacilli.

Authors:  Alessandro Di Cerbo; Beniamino Palmieri; Maria Aponte; Julio Cesar Morales-Medina; Tommaso Iannitti
Journal:  J Clin Pathol       Date:  2015-11-17       Impact factor: 3.411

5.  A comparative study of procedures for binding of aflatoxin M1 to Lactobacillus rhamnosus GG.

Authors:  Jean Claude Assaf; Ali Atoui; André El Khoury; Ali Chokr; Nicolas Louka
Journal:  Braz J Microbiol       Date:  2017-08-06       Impact factor: 2.476

6.  Retrospective analysis of Schlafen11 (SLFN11) to predict the outcomes to therapies affecting the DNA damage response.

Authors:  Sophie E Willis; Claudia Winkler; Martine P Roudier; Tarrion Baird; Paola Marco-Casanova; Emma V Jones; Philip Rowe; Jaime Rodriguez-Canales; Helen K Angell; Felicia S L Ng; Paul M Waring; Darren Hodgson; Jonathan A Ledermann; Johanne I Weberpals; Emma Dean; Elizabeth A Harrington; J Carl Barrett; Andrew J Pierce; Elisabetta Leo; Gemma N Jones
Journal:  Br J Cancer       Date:  2021-10-18       Impact factor: 7.640

Review 7.  Potential role of probiotics on colorectal cancer prevention.

Authors:  Mario Uccello; Giulia Malaguarnera; Francesco Basile; Velia D'agata; Michele Malaguarnera; Gaetano Bertino; Marco Vacante; Filippo Drago; Antonio Biondi
Journal:  BMC Surg       Date:  2012-11-15       Impact factor: 2.102

8.  Effect of dietary honey on intestinal microflora and toxicity of mycotoxins in mice.

Authors:  Aly M Ezz El-Arab; Shenouda M Girgis; Eman M Hegazy; Azzat B Abd El-Khalek
Journal:  BMC Complement Altern Med       Date:  2006-03-14       Impact factor: 3.659

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.